JANICE FENG: Open Payments
NPI 1255039483 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 16 payments from 9 companies in 2025. Trend: 2023 $1,153 · 2024 $1,180 · 2025 $464
Food & beverage: $369Education: $95
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $99 |
| SEAGEN INC. | 1 | $95 |
| Merck Sharp & Dohme LLC | 3 | $76 |
| Eisai Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $30 |
| Janssen Biotech, Inc. | 1 | $27 |
| Telix Pharmaceuticals | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: KEYTRUDA, PADCEV, Lenvima, LYNPARZA, PYLARIFY, ERLEADA, XTANDI, ILLUCCIX.
Industry payments across NY — which companies pay providers there.
